has some big shoes to fill.
Last quarter Tamaddon took over
the now-$5.8-billion T. Rowe Price Health Sciences Fund
] after the resignation of PM Kris Jenner
and analysts Mark Bussard
and Graham McPhail
the mutual fund from Gold to Neutral thanks to worries about the change-up. Now the Wall Street Journal
's worried, too.
In yesterday's monthly investing in funds Journal Report, Daisy Maxey dives deep into the fund and the PM change, noting that Morningstar isn't the only one expressing concern. S&P Capital IQ
downgraded the fun from five stars to four.
Neil Anderson, Managing Editor
Stay ahead of the news ... Sign up for our email alerts now